NCT03636880

Brief Summary

The purpose of this study is to compare a short, behavioral treatment for insomnia with sleep monitoring to determine whether these approaches are effective in reducing insomnia and improving sleep quality among patients with heart failure (HF). This study will also examine the relationship between insomnia and cognitive functioning in HF and the effects of the behavioral treatment on cognitive functioning, self-care, distress, HF symptoms, and functional status. Participants will be randomly assigned to four-sessions of a behavioral treatment (Brief Behavioral Treatment for Insomnia; BBTI) or sleep monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2017

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 8, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 17, 2018

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2023

Completed
Last Updated

April 25, 2024

Status Verified

April 1, 2024

Enrollment Period

6.5 years

First QC Date

August 8, 2018

Last Update Submit

April 24, 2024

Conditions

Keywords

heart failureinsomniaanxietydepressionmemoryattentionexecutive functioningdecision makingself-carequality of lifefunctional statuswalk testsleep monitoring

Outcome Measures

Primary Outcomes (3)

  • Insomnia severity

    Insomnia symptoms will be measured with the 7-item self-report Insomnia Severity Index (ISI). This measure assesses the severity of sleep-onset and sleep maintenance difficulties, sleep satisfaction, as well as associated daytime dysfunction and distress over the prior two weeks. Items are answered on a 5-point Likert-scale from 0 'not at all' to 4 'extremely'. Total scores range from 0 to 28, with higher scores reflective of greater insomnia severity. Scores of 8 or greater indicate the presence of at least mild clinical insomnia.

    Change from pre-intervention to 2 weeks post-intervention

  • Sleep quality assessed by the PSQI

    Sleep quality will be measured with the 19-item self-report Pittsburgh Sleep Quality Index (PSQI). Seven component scores (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medication, and daytime dysfunction) are derived from the instrument which can then be summed to produce a total 'global' PSQI score ranging from 0 to 21. Total PSQI scores greater than 5 indicate poor sleep quality.

    Change from pre-intervention to 2 weeks post-intervention

  • Sleep efficiency

    Sleep efficiency (SE) will be measured with two-week sleep diaries where participants log their daily bed and wake times, as well as the number of hours of sleep each night. SE will be calculated as the percentage of sleep time divided by time spent in bed, with higher percentages indicative of more efficient sleep.

    Change from pre-intervention to 2 weeks post-intervention

Secondary Outcomes (30)

  • Insomnia severity

    Pre-intervention

  • Executive function

    Pre-intervention

  • Memory

    Pre-intervention

  • Attention and psychomotor performance

    Pre-intervention

  • Decision making assessed by the IGT

    Pre-intervention

  • +25 more secondary outcomes

Study Arms (2)

Brief treatment for insomnia

EXPERIMENTAL

Brief Behavioral Treatment for Insomnia (BBTI) is a manualized, individual intervention designed to modify sleep patterns to reduce insomnia and improve sleep quality and efficiency. Participants complete two in-person meetings and two booster telephone calls over a four-week period.

Behavioral: Brief treatment for Insomnia

Sleep Monitoring

ACTIVE COMPARATOR

Sleep Monitoring is an active comparator condition where participants track their sleep patterns for two weeks prior to the baseline and post-intervention assessments. They receive no contact from study staff during the intervening four-week period, except for a reminder call to begin completing the second sleep diary and to schedule the post-intervention assessment.

Behavioral: Sleep Monitoring

Interventions

This behavioral intervention provides participants with an individualized plan to modify sleep patterns contributing to insomnia, as well as education about sleep hygiene and habits that help and hurt sleep.

Also known as: BBTI
Brief treatment for insomnia

This intervention involves using sleep diaries to track daily aspects of sleep, including bed time, wake time, hours of sleep, nighttime awakenings, daytime naps, and sleep quality.

Sleep Monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Fluent in English
  • Diagnosis of heart failure
  • At least mild chronic insomnia

You may not qualify if:

  • Restless legs syndrome
  • Narcolepsy
  • Perform night or rotating shift work
  • Seizure disorder
  • Excessive daytime sleepiness
  • Current or past diagnosis of Bipolar disorder or psychotic disorder
  • Significant cognitive impairments
  • Untreated moderate to severe sleep apnea or high risk for sleep apnea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Heart FailureSleep Initiation and Maintenance DisordersSleep Wake DisordersAnxiety DisordersDepression

Interventions

Crisis Intervention

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSleep Disorders, IntrinsicDyssomniasNervous System DiseasesMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Charles Emery, Ph.D.

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Baseline assessment is completed prior to randomization. Assessments conducted at 2 weeks and 6 months post-intervention are completed by an assessor blinded to participants' assigned condition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 8, 2018

First Posted

August 17, 2018

Study Start

February 24, 2017

Primary Completion

August 29, 2023

Study Completion

August 29, 2023

Last Updated

April 25, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations